Why the Country’s Top Biotech Companies are Flocking to Philadelphia

Regional life sciences industry leaders shared their top reasons for choosing to operate in Greater Philadelphia at the Greater Philadelphia Life Sciences and Innovation Showcase in June.

Bradley Campbell, president and chief operating officer of Amicus Therapeutics explained that his company now operates in Greater Philadelphia because it is where the first FDA-approved gene and cell therapy treatments for genetic diseases were developed.

Many other leaders, such as Dan Hilferty, CEO of Independence Health Group, Carl June of the University of Pennsylvania, Hervé Hoppenot, CEO of Incyte, Maria Fardis, CEO of Iovance Biotherapeutics, and Jeff Marrazzo, Cofounder and CEO of Spark Therapeutics, also shared their experiences of operating in our regions life sciences sector.

Article by Philadelphia Magazine